These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8964863

  • 1. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB, Sullivan K, Garry RF, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander DM, Ahmed B, Bryer-Ash M.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [Abstract] [Full Text] [Related]

  • 2. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S.
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [Abstract] [Full Text] [Related]

  • 3. Immunogenetics of Hashimoto's and Graves' diseases.
    Tamai H, Uno H, Hirota Y, Matsubayashi S, Kuma K, Matsumoto H, Kumagai LF, Sasazuki T, Nagataki S.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM, Barnard J, Farid N, Marshall WH, Murphy L, Rideout D, Taylor R, Xidos G, Larsen B.
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
    Sasazuki T, Inoko H, Morishima S, Morishima Y.
    Adv Immunol; 2016 Apr; 129():175-249. PubMed ID: 26791860
    [Abstract] [Full Text] [Related]

  • 8. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME, Ratanachaiyavong S, Weetman AP, Hall R, McGregor AM.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [Abstract] [Full Text] [Related]

  • 9. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF.
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [Abstract] [Full Text] [Related]

  • 10. A study of human leukocyte D locus related antigens in Graves' disease.
    Farid NR, Sampson L, Noel EP, Barnard JM, Mandeville R, Larsen B, Marshall WH, Carter ND.
    J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a retroviral trigger in Graves' disease.
    Jaspan JB, Luo H, Ahmed B, Tenenbaum S, Voss T, Sander DM, Bollinger K, Baquet T, Garry RF.
    Autoimmunity; 1995 Jan; 20(2):135-42. PubMed ID: 7578870
    [Abstract] [Full Text] [Related]

  • 12. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
    Uchigata Y, Kuwata S, Tsushima T, Tokunaga K, Miyamoto M, Tsuchikawa K, Hirata Y, Juji T, Omori Y.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
    [Abstract] [Full Text] [Related]

  • 13. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [Abstract] [Full Text] [Related]

  • 14. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [Abstract] [Full Text] [Related]

  • 15. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
    Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson PM, Sheppard MC, Barnett AH, Franklyn JA, Gough SC.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3394-7. PubMed ID: 9768636
    [Abstract] [Full Text] [Related]

  • 16. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution.
    Hemminki K, Li X, Sundquist J, Sundquist K.
    J Autoimmun; 2010 May; 34(3):J307-13. PubMed ID: 20056533
    [Abstract] [Full Text] [Related]

  • 17. MHC-extended haplotypes in families of patients with Graves' disease.
    Ratanachaiyavong S, Lloyd L, Darke C, McGregor AM.
    Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
    [Abstract] [Full Text] [Related]

  • 18. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
    Farid NR, Barnard JM, Marshall WH, Woolfrey I, O'Driscoll RF.
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
    [Abstract] [Full Text] [Related]

  • 19. [The effects of HLA class II genes on the susceptibility to autoimmune thyroid diseases].
    Shinagawa H.
    Fukuoka Igaku Zasshi; 1990 Feb; 81(2):97-111. PubMed ID: 2328940
    [Abstract] [Full Text] [Related]

  • 20. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
    Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.